Explore the data
Paxlovid (Nirmatrelvir/Ritonavir) for long COVID
PAXLOVID(NIRMATRELVIR/RITONAVIR) What is Paxlovid? The FDA approved Paxlovid in December 2021 for the acute treatment of COVID-19. According to current guidelines, it is most efficacious if used within the first five days of infection. Paxlovid is a combination of two antiviral medications, nirmatrelvir, and ritonavir, which inhibit the virus's...
August 13, 2024, 09:38 am
![](https://staging.compendirx.com/wp-content/themes/medical-directory-child/assets/img/insta.png")
